PACIRA BIOSCIENCES, INC. Repayments of Debt
PACIRA BIOSCIENCES, INC. (PCRX) reported Repayments of Debt of $0 for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2020-08-06
- PACIRA BIOSCIENCES, INC. repayments of debt for the quarter ending 2020-06-30 was $0.00.
- PACIRA BIOSCIENCES, INC. repayments of debt for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- PACIRA BIOSCIENCES, INC. repayments of debt for the quarter ending 2019-09-30 was $0.00.
- PACIRA BIOSCIENCES, INC. repayments of debt for the quarter ending 2019-06-30 was $0.00.
- PACIRA BIOSCIENCES, INC. repayments of debt for fiscal 2015 was $0.00.
- PACIRA BIOSCIENCES, INC. repayments of debt for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- PACIRA BIOSCIENCES, INC. repayments of debt for fiscal 2013 was $27.50M, a 4.76% increase from fiscal 2012.
- PACIRA BIOSCIENCES, INC. repayments of debt for fiscal 2012 was $26.25M.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2020-08-06 | $338.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $338.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $338.00K 10-Q · filed 2020-05-07 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-02 | |||
| 2017-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $481.00K derived: sum of 2 quarters · filed 2018-11-01 | $118.19M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $479.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $118.19M 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $117.71M 10-Q · filed 2018-05-03 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $4.00K derived: sum of 2 quarters · filed 2017-11-08 | $4.00K 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $4.00K 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-02-25 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $0.00 10-K · filed 2015-02-24 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $0.00 derived: sum of 2 quarters · filed 2014-10-30 | $0.00 10-Q · filed 2014-10-30 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $0.00 10-Q · filed 2014-07-31 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-01 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $27.50M 10-K · filed 2016-02-25 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $0.00 derived: sum of 2 quarters · filed 2014-10-30 | $27.50M 10-Q · filed 2014-10-30 | $27.50M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $27.50M 10-Q · filed 2014-07-31 | $27.50M derived: sum of 3 quarters · filed 2015-02-24 | $27.50M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $27.50M 10-Q · filed 2014-05-01 | $27.50M derived: sum of 2 quarters · filed 2015-02-24 | $27.50M derived: sum of 3 quarters · filed 2015-02-24 | $53.06M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $25.57M derived: sum of 3 quarters · filed 2015-02-24 | $26.25M 10-K · filed 2015-02-24 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $25.57M derived: sum of 2 quarters · filed 2013-10-31 | $26.25M 10-Q · filed 2013-10-31 | |
| 2012-06-30 | $25.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $26.25M 10-Q · filed 2013-08-06 | ||
| 2012-03-31 | $685.00K 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-25 | |||
| 2010-12-31 | $11.25M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |